Profile data is unavailable for this security.
About the company
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.35bn
- Net income in CNY136.37m
- Incorporated2000
- Employees1.30k
- LocationJiangsu Lianhuan Pharmaceutical Co LtdNo.21, Wenfeng RoadYANGZHOU 225127ChinaCHN
- Phone+86 51 487813082
- Fax+86 51 487815079
- Websitehttp://www.lhpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Cheng Yi Pharmaceutical Co Ltd | 706.56m | 148.76m | 2.49bn | 738.00 | 16.25 | 2.00 | -- | 3.41 | 0.4529 | 0.4529 | 2.15 | 3.68 | 0.3938 | 2.11 | 11.86 | 957,393.10 | 8.26 | 12.01 | 10.55 | 14.75 | 65.42 | 69.79 | 20.98 | 22.84 | 0.7041 | -- | 0.2416 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
Novoprotein Scientific Inc | 138.16m | -8.42m | 2.55bn | 579.00 | -- | 1.11 | -- | 17.29 | -0.12 | -0.12 | 1.97 | 30.65 | 0.06 | 0.572 | 2.01 | 238,613.90 | -0.3661 | -- | -0.3779 | -- | 64.49 | -- | -6.10 | -- | 22.83 | -- | 0.034 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
Shanghai Fudan Forward S&T Co Ltd | 648.79m | 7.38m | 2.60bn | 1.36k | 329.69 | 3.14 | -- | 3.82 | 0.011 | 0.011 | 0.9508 | 1.15 | 0.3778 | 0.6215 | 7.41 | 476,003.60 | 0.4294 | -0.8781 | 0.7407 | -1.53 | 38.30 | 43.22 | 1.14 | -1.85 | 0.4148 | -4.48 | 0.395 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.35bn | 136.37m | 2.65bn | 1.30k | 18.67 | 1.85 | -- | 1.09 | 0.4777 | 0.4777 | 8.22 | 4.81 | 0.8255 | 3.44 | 4.60 | 1,810,024.00 | 5.50 | 5.93 | 11.40 | 11.25 | 48.56 | 53.26 | 6.66 | 7.82 | 0.7093 | 6.96 | 0.3522 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
Zhejiang Shapuaisi Pharmaceutical Co Ltd | 540.27m | -72.66m | 2.71bn | 1.39k | -- | 1.65 | -- | 5.16 | -0.1922 | -0.1922 | 1.44 | 4.46 | 0.2581 | 2.94 | 13.86 | 390,086.00 | -3.48 | -0.7573 | -4.00 | -0.8713 | 51.90 | 58.02 | -13.49 | -2.45 | 0.8094 | -- | 0.1284 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
Ningbo Menovo Pharmaceutical Co Ltd | 1.24bn | -326.25k | 2.81bn | 2.35k | 8,619.72 | 1.27 | -- | 2.16 | -0.0323 | -0.0323 | 5.32 | 9.67 | 0.2802 | 1.29 | 5.28 | 527,886.10 | 0.0661 | 4.94 | 0.0989 | 7.83 | 29.16 | 35.39 | 0.2359 | 13.71 | 0.78 | 1.89 | 0.4176 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
Data as of Oct 11 2024. Currency figures normalised to Jiangsu Lianhuan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Taiping Fund Management Co., Ltd.as of 31 Dec 2023 | 241.00k | 0.08% |
Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 2023 | 38.30k | 0.01% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 25.60k | 0.01% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 7.70k | 0.00% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.60k | 0.00% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.80k | 0.00% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 900.00 | 0.00% |
Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 100.00 | 0.00% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.